Drug and Alcohol Clinical Care
Part 3: Drug & Alcohol Addiction Series

Overview of Key Evidence-Based & Trauma-Informed Therapeutic Treatment & Practice

This webinar will provide an overview of key evidence based therapeutic treatments and trauma informed practice for drug and alcohol clinical care. Natasha will address the challenges of targeting treatment to a diverse population group from mild problems with substances through to severe substance use disorders, maintaining a focus on patient factors beyond diagnostics. The importance of treatment processes fundamental to any drug and alcohol treatment will be described, targeting client engagement, retention in therapy and substance use outcomes. The webinar will also mention therapeutic considerations for mental health comorbidity and specific population groups. The presentation will be embedded with reflective exercises throughout, and a list of resources will also be provided for further learning. 

Book Webinar

Cost

$44AUD
Includes 60 day recording access

Date

Friday 5th November 2021
2pm - 3pm (AEDT)

About the Presenter

Natasha

Dr Natasha Perry is a Senior Clinical and Health Psychologist and works as a Clinical Leader in Drug and Alcohol Clinical Services, Hunter New England Local Health District. In her role, she utilises her clinical experience and expertise to lead initiatives that aim to improve the quality of care for people accessing the health service. She completed her Doctor of Clinical and Health Psychology at the University of Newcastle, where she is a Clinical Lecturer for the School of Psychology, College of Engineering, Science and Environment. Natasha is a member of the small expert reference group for the NSW Health Drug and Alcohol Psychosocial Interventions Professional Practice Guidelines due to publication later this year. She has previously undertaken clinical research and delivered treatment programs to improve the quality of life for people who use substances. Throughout her career, Natasha has written scientific journal articles, co-written textbook chapters and has had her work presented at several national and international conferences. She was awarded a Churchill Fellowship in 2016 which took her to on an extensive worldwide trip investigating the effectiveness of treatment programs for young people with substance use problems and related complexities. Natasha likes to work from a reflective practice and trauma informed bio-psycho-socio-cultural framework and is passionate about integrating theory and evidence into practice and tailoring treatment to clients’ individual needs.

Outside of work, she enjoys drawing, food, travel and has a newfound passion biophilic design for wellness. Natasha is currently on maternity leave with her two boys and happily spends her time at parks, playing with trucks and making sandcastles.


Drug & Alcohol Addiction is a 6-Part series:

This 6-part series presented live during October and November 2021 can be purchased as an entire set to participate in all 6 parts for the price of 5 webinars! The entire series is valued at $264AUD.

Join Whole Series $220

6 part series on Addiction


Part 1: Substance Use Assessments: Platforms for Change with Kynan Cliff

part 1

People with co-occurring mental health and substance use issues are faced with increased risk of illness and injury (including self-harm and suicide), poorer psychiatric and physical outcomes, increased risk of side effects and less efficacious treatment (NSW Health 2009). Structural issues such as stigma and a fractured and under-resourced service system limit access to quality, evidence-based and effective care for this vulnerable client population. The assessment process represents an opportunity for clinicians to have curious conversations with clients; explore the function of their substance use; and open up conversations about change.

Read More


Part 2: Pharmacotherapies in Addiction Medicine with Dr Craig Sadler

part 2

This webinar will provide and overview of the latest evidence-based pharmocotherapies used in:

  • Managing substance withdrawal;
  • Managing alcohol dependence including Acamprosate / naltrexone / disulfiram / other potential pharmacotherapies for alcohol.
  • Managing Opioid addiction including Methadone and buprenorphine including depot formulations
  • Dr Sadler will also discuss novel and evolving pharmacotherapies for other drugs.

Read More


Part 3: Overview of Key Evidence-Based & Trauma-Informed Therapeutic Treatment & Practice for Drug and Alcohol Clinical Care with Dr Natasha Perry

Part 3

This webinar will provide an overview of key evidence based therapeutic treatments and trauma informed practice for drug and alcohol clinical care. Natasha will address the challenges of targeting treatment to a diverse population group from mild problems with substances through to severe substance use disorders, maintaining a focus on patient factors beyond diagnostics. The importance of treatment processes fundamental to any drug and alcohol treatment will be described, targeting client engagement, retention in therapy and substance use outcomes. The webinar will also mention therapeutic considerations for mental health comorbidity and specific population groups. The presentation will be embedded with reflective exercises throughout, and a list of resources will also be provided for further learning. 

Read More


Part 4: Motivational Interviewing with Dr Kylie Bailey

part 4

Motivational interviewing is an essential and evidence-based tool that all health professionals need to learn so that they can maximise appointment times and improve treatment outcomes. Motivational interviewing is applied in therapy sessions, brief interventions and is effective in short appointment times, busy wards, pharmacy settings and emergency departments. This therapy approach emphasises the importance of listening to the patient and hearing their reasons for change and working through the barriers to achieving their goals. This webinar aims to provide you with an understanding of motivational interviewing, how it can help you and review the core skills that you can practice in supervision and with your patients.

Read More


Part 5: Relapse Prevention with Dr Julian Keats

part 5

Addiction is often described as a chronic relapsing and remitting disorder in which patients fluctuate between periods of heavier and more problematic substance use and periods of more controlled substance use, including abstinence for some. The challenges of preventing and/or managing relapse are therefore a core component of the long-term treatment approach needed for substance use disorders.

Read More


Part 6: Substance-Induced Psychosis with Dr Tarun Yadav

part 6

This webinar will provide a thorough overview of Substance-Induced Psychosis, including epidemiology; neurobiology, Clinical formulation to differentiate from other disorders and a thorough summary of the latest evidence-based treatment recommendations. This webinar is a must for anyone working with substance addiction and dependence.

Read More

Page Last Updated: 16 August 2021

}